The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Inflammatory marker levels and prediction of patient-reported symptoms in patients with advanced pancreatic cancer receiving gemcitabine-based chemotherapy.
Xin Shelley Wang
No relevant relationships to disclose
Qiuling Shi
No relevant relationships to disclose
Donghui Li
No relevant relationships to disclose
Cathy Eng
No relevant relationships to disclose
Raza H Bokhari
No relevant relationships to disclose
David R. Fogelman
No relevant relationships to disclose